PNOĒ
PrivateLast Round
Accelerator
Jan 1, 2019
Est. Valuation
$2.14M
Total Funding Raised
$150,000
Company Overview
PNOĒ operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was an Accelerator round in January 2019.
PNOĒ is a biotechnology company that has developed a portable cardio-metabolic analysis system for breath analysis to provide personalized nutrition and fitness plans.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sports & Fitness, Precision Medicine, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PNOĒ Comparables
Compare PNOĒ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VO2 Master | 85% | |
| Splendo Health | 81% | |
| Breezing Co. | 79% |
For institutional investors. Book with your work email.
PNOĒ Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PNOĒ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 49% MoM.
- Jul 4, 2025
Monthly visitors increased 45% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 28, 2026
PNOĒ Inc. raises an $11M round backed by 50 Years and Google Maps co-founder Lars Rasmussen, bringing its total funding since Y Combinator’s Winter 2019 batch to roughly $22 million.
- launchesSep 27, 2026
PNOĒ Inc. prepares to launch the PNOĒ 2.0, a self-serve breath-testing device that measures oxygen consumption and carbon dioxide exhalation, on Oct 1st '26.
For institutional investors. Book with your work email.
PNOĒ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PNOĒ's valuation, stock price, and market status.
Is PNOĒ a public or private company?
PNOĒ is a private company.
What is the current stock price of PNOĒ?
PNOĒ is a private company, so its shares have no public market price. Caplight tracks PNOĒ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PNOĒ worth (valuation)?
PNOĒ's valuation is estimated at $2.1M based on funding round data.
Can I buy PNOĒ stock?
PNOĒ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PNOĒ's last funding round?
PNOĒ's most recent funding round was Accelerator on January 1, 2019.
Who are the main investors in PNOĒ?
Key investors in PNOĒ include Y Combinator.
Will PNOĒ IPO soon?
No public IPO plans have been announced for PNOĒ.
How can I track PNOĒ secondary market activity?
Caplight tracks bids, offers, and trades in PNOĒ's shares on secondary markets.